We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Final Guidances on Drug Risk Management Won't Burden Industry, FDA Says
Final Guidances on Drug Risk Management Won't Burden Industry, FDA Says
March 24, 2005
A trio of final guidance documents focused on developing new ways to minimize the safety risks of prescription drugs and biologics are not expected to lengthen the product- approval process, a top FDA official said.